Litigation Details for Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

Docket		Date Filed	2023-10-18
Court	Court of Appeals for the Federal Circuit	Date Terminated	2024-08-13
Cause		Assigned To
Jury Demand		Referred To
Patents	10,188,632; 7,741,356; 7,786,158; 8,344,011; 8,609,709; 8,691,860; 8,772,325; 9,000,011; 9,115,091; 9,205,076; 9,364,489; 9,675,587; 9,700,542; 9,789,125
Link to Docket	External link to docket

Details for Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-12-28	17		)(IV) for U.S. Patent Nos. 9,675,587 (the '" 587 patent") and 10,188,632 (the "'… 10,188,632 B2 1/2019 Costello et al. …588,304, filed on May 5, 2017, now Pat. No. 10,188,632, which is a continuation of …associated with altered bowel habits (Drossman D 10,188,632, granted on Jan. 29, 2019; which is a continua… 10,188,632 B2 1/2019 Costello et al. (22)	External link to document
2024-01-29	19		231) ’626 patent U.S. Patent No. 6,452,626 ’632 patent U.S. Patent No. 10,188,632 (Appx48-72…earlier patents in the same family: U.S. Patent Nos. 9,675,587 (the “’587 patent”) and 10,188,632 (the …ABBREVIATIONS ’011 patent U.S. Patent No. 8,344,011 ’036 patent U.S. Patent No. 6,862,036 ’… ’179 patent U.S. Patent No. 11,007,179 (Appx73-101) ’356 patent U.S. Patent No. 7,741,356…14485) ’516 patent U.S. Patent No. 11,311,516 (Appx183-209) ’587 patent U.S. Patent No. 9,675,587	External link to document
2024-02-20	21		ABBREVIATIONS ’356 patent U.S. Patent No. 7,741,356 (Appx14407-14485) ’011 patent U.S.…U.S. Patent No. 8,344,011 ’709 patent U.S. Patent No. 8,609,709 ’516 patent U.S. Patent…the ’375 patent was not a proper reference patent for the ’483 patent because the ’375 patent issued later…original patent monopoly period, and that later-filed, later-expiring patents with patentably indistinct… filed patent is not a proper ODP reference patent for the first-filed, first-issued patent in the family	External link to document
2024-08-29	40		disclaimer with respect to U.S. Patent No. 7,741,356 (the “’356 patent”) by March 14, 2025, to preserve…the ʼ356 patent were subject to obviousness-type double patenting in view of reference patents that will…terminal disclaimer for the ʼ356 patent does not apply to whether other patents in this appeal are invalid…ʼ356 patent, the panel reversed the district court’s judgment of obviousness-type double patenting. Id…Allergan to file a terminal disclaimer for the ʼ356 patent. Regardless, March 14, 2025, is more than six months	External link to document